International Conference on
Vaccines & Vaccination
Vaccine 2018
Theme: Understanding the Importance of Vaccines in the Present Era
Meetings International takes the pride in announcing its premier International Conference on Vaccines & Vaccination scheduled in Osaka, Japan during July 23-24, 2018. A leading forum for Microbiologist, researchers, scientists, elite professors, Technologist and students provides the ideal environment to disseminate and gain current knowledge in this field.The main theme of the conference is ''Understanding the Importance of Vaccines in the Present Era''
Meetings International provides a global platform for Medical, Biotech, Pharmaceutical and Healthcare Professionals to Exchange Ideas, Knowledge and Networking at International Conferences. It supports broad scope research and peer review at a broad range of specialists around the world. The key strategic objective of Meetings International is to communicate science and medical research between academia and industry.
Vaccine Conference brings upon an incipient platform to share and discuss all the innovations and potential benefits and limitations of vaccines in preventing and control of diseases. The gathering incorporates Plenary lectures, keynote talks courses by eminent personalities from around the world in addition to poster presentation, young researcher sessions, symposiums, workshop and Exhibitions. It focuses on a wide array of topics that include the following: New Vaccines, Infectious diseases & Non Infectious Diseases, Cancer Vaccines, Veterinary Vaccines, Trials in Vaccinology, Novel Vaccines, Pregnancy & Neonantal Vaccines, Vaccine-Preventable Diseases, Therapeutic Vaccination and Immunizations, Passive vaccines, Vaccine Regulation and its Safety & Efficacy, Emerging and Re-emerging diseases, Hepatitis Vaccines, HIV/AIDS Vaccines.
Vaccine Conference leads confident that it will definitely offer all participants an unforgettable experience in exploring new opportunities. Hoping everyone to join us for this event in Osaka.Osaka is a designated city in the Kansai region of Japan. It was evaluated in Research & Development only. Osaka currently markets vaccines in Japan only and is growing its vaccine pipeline, including R&D projects for dengue and chikungunya. Osaka performs above average in Research & Development, and has clear access provisions for its late-stage vaccine candidate. While it does not currently market vaccines in countries in scope, it is taking steps to support affordability and supply of vaccines in its pipeline.
Session 1: New Vaccines
Vaccines are necessary and good hygiene, sanitation, clean water, and nutrition are insufficient for stopping infectious diseases. If we don’t maintain optimum rates of immunization or “herd immunity”, the diseases prevented by vaccination will return. . A Traditional vaccine consists of agents that resemble the disease- causing organism. When these agents enter the human body they stimulate the immune system to recognize these agents as foreign and destroy them.
Vaccine Conference, Vaccination Conference , Vaccines Events, Vaccination Actions, Vaccination Program , Vaccines Symposium , Vaccination Workshop, Vaccines Meetings, Vaccine Congress, Genetic Vaccines and Therapy Conference, Travel Medicine and Vaccines Meetings, Vaccine Biotechnology Congress , Conference on Veterinary Vaccinology, Bioinformatics for Vaccinology Symposium, Vaccines and Clinical Trials Meetings, Human Vaccine And Therapeutics Congress, Workshop on Vaccine Research Work, Global Vaccines and Immunology Conference.
Session 2: Infectious diseases & Non Infectious Diseases
The first vaccines for humans against viruses used weakened viruses to generate immunity without causing severe illness (e.g. the early smallpox vaccine that was derived from cowpox). The rabies vaccine was the first human vaccine where the virus was attenuated in a laboratory. vaccines against chronic infectious diseases aim at eliciting broad humoral and cellular immune responses against multiple target antigens.. It covers infectious disease targets and non-infectious disease targets.
Genetic Vaccines and Therapy Conference, Travel Medicine and Vaccines Meetings, Vaccine Biotechnology Congress , Conference on Veterinary Vaccinology, Vaccine Conference, Vaccination Conference , Vaccines Events, Vaccination Actions, Vaccination Program , Vaccines Symposium , Vaccination Workshop, Vaccines Meetings, Vaccine Congress, Human Vaccine And Therapeutics Congress, Workshop on Vaccine Research Work, Global Vaccines and Immunology Conference, Bioinformatics for Vaccinology Symposium, Vaccines and Clinical Trials Meetings.
Session 3: Cancer Vaccine
Cancer treatment vaccines are different from the vaccines that work against viruses. These vaccines endeavor to get the immune system to mount an assailment against cancer cells in the body. In lieu of averting disease, they are betokened to get the immune system to assail a disease that already subsists. Cancer vaccines work the same way, but they make the person’s immune system attack cancer cells. The goal is to avail treat cancer or to avail keep it from coming back after other treatments. But there are additionally some vaccines that may authentically avail avert certain cancers. These vaccines are made from genuine cancer cells that have been abstracted from the patient during surgery. The cells are altered (and killed) in the lab to make them more liable to be assailed by the immune system and then injected back into the patient. The patient’s immune system then assails these cells and any homogeneous cells still in the body.
Human Vaccine And Therapeutics Congress, Workshop on Vaccine Research Work, Global Vaccines and Immunology Conference, Genetic Vaccines and Therapy Conference, Travel Medicine and Vaccines Meetings, Vaccine Biotechnology Congress , Conference on Veterinary Vaccinology, Vaccine Conference, Vaccination Conference , Vaccines Events, Vaccination Actions, Vaccination Program , Vaccines Symposium , Vaccination Workshop, Vaccines Meetings, Vaccine Congress.
Sessions 4: Veterinary Vaccines
Veterinary vaccines are to improve the health and welfare of animals and also protect its health along public health, reducing animal suffering, enabling efficient production of food animals to feed the burgeoning human population, and greatly reducing the need for antibiotics to treat food and companion animals. Prominent examples include rabies vaccines and rinderpest vaccines. Recently for rabies a third generation rabies vaccine has been developed using recombinant technology for domestic animals and wildlife. Depending upon the expression system these vaccines are used either parenterally or orally. Oral rabies vaccines are widely used in foxes in Europe and in racoons in the USA.
Human Vaccine And Therapeutics Congress, Workshop on Vaccine Research Work, Global Vaccines and Immunology Conference, Genetic Vaccines and Therapy Conference, Travel Medicine and Vaccines Meetings, Vaccine Biotechnology Congress , Conference on Veterinary Vaccinology, Vaccine Conference, Vaccination Conference , Vaccines Events, Vaccination Actions, Vaccination Program , Vaccines Symposium , Vaccination Workshop, Vaccines Meetings, Vaccine Congress.
Session 5: Trails in Vaccinology
A vaccine trial establishes the safety and efficacy of a vaccine prior to it being licensed. A vaccine trial might involve forming two groups from the target population. Vaccine trials may take months or years to complete, since a sufficient time period must elapse for the subjects to react to the vaccine and develop the required antibodies.
Genetic Vaccines and Therapy Conference, Travel Medicine and Vaccines Meetings, Vaccine Biotechnology Congress , Conference on Veterinary Vaccinology, Vaccine Conference, Vaccination Conference , Vaccines Events, Vaccination Actions, Vaccination Program , Vaccines Symposium , Vaccination Workshop, Vaccines Meetings, Vaccine Congress, Human Vaccine And Therapeutics Congress, Workshop on Vaccine Research Work, Global Vaccines and Immunology Conference, Bioinformatics for Vaccinology Symposium, Vaccines and Clinical Trials Meetings.
Session 6: Novel Vaccines
Vaccines have led to the global eradication of smallpox, the near global eradication of polio, and phenomenal reductions in measles infections in most of the developed world, The revelation of vaccinations has provoked to the nearby demolition of a couple of basic diseases and has enormously influenced prosperity for a decently insignificant exertion.
Vaccine Conference, Vaccination Conference , Vaccines Events, Vaccination Actions, Vaccination Program , Vaccines Symposium , Vaccination Workshop, Vaccines Meetings, Vaccine Congress, Genetic Vaccines and Therapy Conference, Travel Medicine and Vaccines Meetings, Vaccine Biotechnology Congress , Conference on Veterinary Vaccinology, Bioinformatics for Vaccinology Symposium, Vaccines and Clinical Trials Meetings, Human Vaccine And Therapeutics Congress, Workshop on Vaccine Research Work, Global Vaccines and Immunology Conference.
Session 7: Pregnancy & Neonantal Vaccines
Vaccines are given specifically depending on factors such as age, lifestyle, medical conditions , such as asthma or diabetes, type and locations of travel, and previous vaccinations. Benefits of vaccinating pregnant women usually outweigh potential risks when the likelihood of disease exposure is high, when infection would pose a risk to the mother or foetus, and when the vaccine is unlikely to cause harm. There is a unique CDC rules for the immunizations which are require after pregnancy.
Genetic Vaccines and Therapy Conference, Travel Medicine and Vaccines Meetings, Vaccine Biotechnology Congress , Conference on Veterinary Vaccinology, Vaccine Conference, Vaccination Conference , Vaccines Events, Vaccination Actions, Vaccination Program , Vaccines Symposium , Vaccination Workshop, Vaccines Meetings, Vaccine Congress, Human Vaccine And Therapeutics Congress, Workshop on Vaccine Research Work, Global Vaccines and Immunology Conference, Bioinformatics for Vaccinology Symposium, Vaccines and Clinical Trials Meetings.
Session 8: Vaccine-Preventable Diseases
Viral and bacterial vaccines decrease the percentile of severity of illness in the living being and reduce the transmission of the pathogens to other susceptible living being. Viral vaccines contain inactivated viruses (alive but not capable of causing disease) thus they lost their ability to replicate and in order for it to bring about a response it contains more antigen than live vaccines. Attenuated or live vaccines contain the live form of the virus. These viruses are not pathogenic but are able to induce an immune response. Through these mechanisms, vaccines against smallpox, polio, measles and hepatitis B have had an enormous impact on world health over the last 50 years.
Genetic Vaccines and Therapy Conference, Travel Medicine and Vaccines Meetings, Vaccine Biotechnology Congress , Conference on Veterinary Vaccinology, Vaccine Conference, Vaccination Conference , Vaccines Events, Vaccination Actions, Vaccination Program , Vaccines Symposium , Vaccination Workshop, Vaccines Meetings, Vaccine Congress, Human Vaccine And Therapeutics Congress, Workshop on Vaccine Research Work, Global Vaccines and Immunology Conference, Bioinformatics for Vaccinology Symposium, Vaccines and Clinical Trials Meetings.
Session 9: Therapeutic Vaccination and Immunization
The vaccination helps the immune system to recognize and fight specific germs. Perfect immunity against a disease is not guaranteed through vaccination. Immunization refers to making someone immune against infections or diseases. Immunization is not only caused by Vaccines but there are also some diseases that cause immunization after an individual encounters and recovers from that disease.
Genetic Vaccines and Therapy Conference, Travel Medicine and Vaccines Meetings, Vaccine Biotechnology Congress , Conference on Veterinary Vaccinology, Vaccine Conference, Vaccination Conference , Vaccines Events, Vaccination Actions, Vaccination Program , Vaccines Symposium , Vaccination Workshop, Vaccines Meetings, Vaccine Congress, Human Vaccine And Therapeutics Congress, Workshop on Vaccine Research Work, Global Vaccines and Immunology Conference, Bioinformatics for Vaccinology Symposium, Vaccines and Clinical Trials Meetings.
Session 10: Passive vaccines
For many laboratory techniques antibodies are vital. Even the molecules which cannot be seen by naked eyes are visible now due to their specificity and thus enable conclusions to be drawn about the target molecule and pathway of interest. Immunizer Genetic Engineering and Therapeutics meeting united a wide scope of members who were refreshed on the most recent advances in counter acting agent innovative work.
Vaccine Conference, Vaccination Conference , Vaccines Events, Vaccination Actions, Vaccination Program , Vaccines Symposium , Vaccination Workshop, Vaccines Meetings, Vaccine Congress, Genetic Vaccines and Therapy Conference, Travel Medicine and Vaccines Meetings, Vaccine Biotechnology Congress , Conference on Veterinary Vaccinology, Bioinformatics for Vaccinology Symposium, Vaccines and Clinical Trials Meetings, Human Vaccine And Therapeutics Congress, Workshop on Vaccine Research Work, Global Vaccines and Immunology Conference.
Session 11: Vaccine Regulation and its Safety & Efficacy
Vaccines are some of the safest medical products available, but like any other medical product, there may be health risk. Accurate information about the value of vaccines as well as their possible side-effects helps people to make informed decisions about vaccination. Vaccine efficacy is the ability of vaccines to bring about the intended beneficial effects on vaccinated individuals in a defined population under ideal conditions of use. The potential benefits of an effective vaccine.
Genetic Vaccines and Therapy Conference, Travel Medicine and Vaccines Meetings, Vaccine Biotechnology Congress , Conference on Veterinary Vaccinology, Vaccine Conference, Vaccination Conference , Vaccines Events, Vaccination Actions, Vaccination Program , Vaccines Symposium , Vaccination Workshop, Vaccines Meetings, Vaccine Congress, Human Vaccine And Therapeutics Congress, Workshop on Vaccine Research Work, Global Vaccines and Immunology Conference, Bioinformatics for Vaccinology Symposium, Vaccines and Clinical Trials Meetings.
Session 12: Emerging and Re-emerging diseases
Emerging infectious diseases present many hindrances with regard to vaccine development. The major obstacles to development of vaccines against emerging infectious diseases have generally not been regulatory in nature. In many cases, the scope of the threat from an emerging infectious disease is unknown at the time when vaccine development would optimally occur.
Genetic Vaccines and Therapy Conference, Travel Medicine and Vaccines Meetings, Vaccine Biotechnology Congress , Conference on Veterinary Vaccinology, Vaccine Conference, Vaccination Conference , Vaccines Events, Vaccination Actions, Vaccination Program , Vaccines Symposium , Vaccination Workshop, Vaccines Meetings, Vaccine Congress, Human Vaccine And Therapeutics Congress, Workshop on Vaccine Research Work, Global Vaccines and Immunology Conference, Bioinformatics for Vaccinology Symposium, Vaccines and Clinical Trials Meetings.
Session 13: Hepatitis Vaccines
Hepatitis is an inflammation of the liver. The condition can be self-limiting or can progress to fibrosis (scarring), cirrhosis or liver cancer. Hepatitis viruses are the most common cause of hepatitis in the world but other infections, toxic substances (e.g. alcohol, certain drugs), and autoimmune diseases can also cause hepatitis. Hepatitis Vaccines are many depending on its Category.
Vaccine Conference, Vaccination Conference , Vaccines Events, Vaccination Actions, Vaccination Program , Vaccines Symposium , Vaccination Workshop, Vaccines Meetings, Vaccine Congress, Genetic Vaccines and Therapy Conference, Travel Medicine and Vaccines Meetings, Vaccine Biotechnology Congress , Conference on Veterinary Vaccinology, Bioinformatics for Vaccinology Symposium, Vaccines and Clinical Trials Meetings, Human Vaccine And Therapeutics Congress, Workshop on Vaccine Research Work, Global Vaccines and Immunology Conference.
Session 14: HIV/AIDS Vaccines
Development of a HIV/AIDS immunization has been ease back on the grounds that established ways to deal with antibody improvement have not yielded an antibody. An AIDS vaccine does not yet exist, but efforts to develop a vaccine against HIV, the virus that causes AIDS, have been underway for many years. An HIV vaccine could be effective in either of two ways. A preventive vaccine would stop HIV infection occurring altogether, whereas a therapeutic vaccine would not stop infection, but would prevent or delay illness in people who do become infected, and might also reduce the risk of them transmitting the virus to other people. Although a preventive vaccine would be ideal, therapeutic vaccines would also be highly beneficial. The basic idea behind all HIV vaccines is to encourage the human immune system to fight HIV.
Genetic Vaccines and Therapy Conference, Travel Medicine and Vaccines Meetings, Vaccine Biotechnology Congress , Conference on Veterinary Vaccinology, Vaccine Conference, Vaccination Conference , Vaccines Events, Vaccination Actions, Vaccination Program , Vaccines Symposium , Vaccination Workshop, Vaccines Meetings, Vaccine Congress, Human Vaccine And Therapeutics Congress, Workshop on Vaccine Research Work, Global Vaccines and Immunology Conference, Bioinformatics for Vaccinology Symposium, Vaccines and Clinical Trials Meetings.
Why Japan?
Osaka was evaluated in Research & Development only. Osaka currently markets vaccines in Japan only and is growing its vaccine pipeline, including R&D projects for dengue and chikungunya. Osaka performs above average in Research & Development, and has clear access provisions for its late-stage vaccine candidate. While it does not currently market vaccines in countries in scope, it is taking steps to support affordability and supply of vaccines in its pipeline. For example, from 2016, Osaka has been developing a low-cost IPV with support from the Bill & Melinda Gates Foundation. The beginning stages of early traditions of visits to lovely destinations. Japan's rich history can be experienced most wherever in the country. With numerous old royal residences so far remaining the nation over, it's definitely not hard to set aside a trip back in chance to a place that is known for medieval rulers. The Travel and Tourism Competitiveness Report 2017 positions Japan fourth out of 141 countries for the most part, which was the best in Asia. Japan got for the most part high scores in all viewpoints, especially human services and cleanliness, wellbeing and security, social resources and business travel.
Vaccine & Vaccination Market Research
Importance and scope
Vaccination is one of the most successful achievements in medicine. Vaccine Immunology upgrades our comprehension of the resistant reaction in wellbeing and illness by exhibiting critical clinically applicable research, including new creature models for human immunologic infections. Vaccination itself cannot cause formation of disease against which it is intended. Vaccines have historically been the most effective means to fight and eradicate infectious diseases. Vaccinations of animals are used both to prevent their contracting diseases and to prevent transmission of disease to humans. Vaccination given during childhood is generally safe. Effectiveness of vaccination is unambiguously proven by regression up-to clearance of many diseases preventable by vaccination. Limitations to their effectiveness, nevertheless, exist. Influence of vaccination can be best illustrated on eradication of smallpox in the world one of the most contagious and deadly diseases in humans.
Global Vaccine Market
The vaccines market is expected to reach USD 49.27 Billion by 2022 from USD 34.30 Billion in 2017, at a CAGR of 7.5%. The growth of the market is attributed to the rising prevalence of diseases, increasing government and nongovernment funding for vaccine development, and increasing investments by companies.
Newer and more expensive vaccines are coming into the market faster than ever before. Vaccine development: increasing investment. Tripled in value from USD 5B in 2000 to almost USD 24 B in 2013 – Influenza vaccine market: estimated at $2.9 billion in 2011 to $3.8 billion by 2018 – US : $1.6 billion in 2011 to $2.2 billion in 2018. Global market projected to rise to USD 100 B by 2025 .More than 120 new products in the development pipeline. Changing status of the vaccines within the pharmaceutical industry . New business model for vaccines is emerging.
Global Statistics of Vaccines
Global Influenza Vaccine Market – Will Increase to US$ 5.74 Billion by the Year 2022 – Research and Markets.
The study based on Evaluate Pharma survey shows that at the end of 2013 the sales volume of global vaccine market was $ 25.6 billion and is expected to rise to $41.3 billion by 2020.
Global antibacterial vaccination market
Global Antibacterial Drugs Market to 2022: Antibacterial Drug Market will Hit $35.6 Billion by 2022, as Efforts Increase to Tackle Antimicrobial Resistance - Research and Markets.
Global antibacterial vaccination market is expected to experience healthy growth across the forecast period due to rising profits for several classes of drugs. Vaccines will still be the leading revenue-generating drugs in the market in 2022, despite the influx of new protein synthesis inhibitors and the release of several new cell-wall synthesis inhibitors.
Conjugate vaccines to dominate the market in 2017-2018
Predicated on technology, the vaccines market is segmented into conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, and toxoid vaccines. In 2018, the conjugate segment is expected to account for the most immensely colossal quota of the vaccines market. The magnification in this market is mainly driven by incrementing investments by the regime of developing countries and elevating prevalence of infectious diseases.
Predicated on disease denotement, the pneumococcal segment is projected to grow at the highest CAGR during the forecast period.
By disease designation, the vaccines market is segmented into pneumococcal disease, influenza, DTP, hepatitis, human papillomavirus (HPV), rotavirus, meningococcal disease, MMR (measles, mumps, and rubella), varicella, polio, dengue, and other disease designations. The pneumococcal segment is expected to register the highest rate during the forecast period. The magnification in this segment can primarily be attributed to the incrementing regime investments in pneumococcal vaccination programs and high prevalence of pneumococcal disease.
Market outlook of the global human vaccine market
Technavio’s market research analyst presages the ecumenical human vaccine market to grow rapidly at a CAGR of more than 11% by 2020. This market’s steady magnification rate is heavily influenced by the inclusion of several pediatric vaccines in the national immunization schedule of sundry countries. This avails in incrementing the consumption of vaccines, which in turn fosters market magnification during the prognosticated period.
America Region
The global vaccines market is segmented based on technology, type, disease indication, end-users, and regions. The conjugate vaccines segment is expected to register the highest growth rate in the vaccines market, by technology, during the forecast period. The high growth in this segment is attributed to the increasing company investments in development of new vaccines.
The vaccines market is expected to reach $48.03 billion by 2021 from USD 32.24 billion in 2016 at a CAGR of 8.3% driven by increasing focus on immunization programs and rising government and nongovernment funding for vaccine development while North America is expected to dominate the market globally.
Europe Region
The Vaccines Europe surveys, provide an insight into the innovation, research and development, employment and manufacturing undertaken by the industry in Europe. With the information collected every two years, Vaccines Europe’s database reveals industrial trends that can assist policy makers and other stakeholders concerned with Europe’s social and economic development.
Europe Influenza Vaccine Market was close to US$ 1Billion. In children vaccine market, United Kingdom is ahead and France holds the second spot. In adult vaccine market United Kingdom and Germany have are on equilibrium.
Asia pacific Region
The Asia-Pacific Cancer Vaccines Market was worth $ 0.46 billion in 2016 and estimated to reach $ 1.05 billion by the end of 2021 with a growing potential of 18.24 %. The Asia-Pacific DNA vaccine market was estimated to be worth $154 million in 2016. The market is predicted to grow at the highest CAGR of 45.85% over the forecast period of 2017-2025, generating $4874 million by its end.
Middle East Region
The Middle East and Africa offer immense potential and opportunities for the vaccine market. Apart from the unmet needs for vaccination, second most important market driving factor are the policies of national Governments and international bodies such as World health organization (WHO).
The market’s trends include strong research pipeline under which number of novel vaccines are being developed such as rubella vaccine, ebola vaccine etc. DNA recombinant technology is also a common technology used in the development of novel acting vaccines.
Associations & Societies Associated with Vaccines in and around Osaka:
- Japanese Society for Immunology(JSI)
- The Japanese Society for Vaccinology
- The Japanese Society of Virology
- The Japanese Association Of Medical Sciences
- Japan Society of Immunology and Reproduction
- Japan Pediatric Society
Global Associations & Societies Associated with Vaccines:
- European Federation of Immunological Societies, Itlay
- The International Society for Interferon and Cytokine Research, USA
- The International Society of Neuroimmunology, Itlay
- British Society for Immunology, UK
- Infectious Diseases Society of America, USA
- The Society for Mucosal Immunology, UK
- The Society for Leukocyte Biology, Germany
- Immune Deficiency Foundation., USA
- The International Union of Immunological Societies, Germany
- European Society of Gene Therapy, Germany
- Federation of African Immunological Societies, Tunisia
- Federation of Clinical Immunology Societies, USA
Universities associated with Vaccines globally:
- Osaka University, Japan
- Angeles University Foundation, Philippines
- Moscow State Medical University, Russia
- Shanghai Medical University, China
- Qingdao University, China
- University of Jordan, Jordan
- Kasr El-Aini Faculty of Medicine, Cairo University, Egypt
- Arak University of Medical Sciences, Iran
- Oman Medical College, Oman
- Riyadh.College of medicine, Saudi Arabia
- University of Minho, Portugal
- Medical University of Lublin, Poland
- Saba University School of Medicine, Netherlands
- University of Western Brittany, France
- University of Southern Denmark, Denmark
- Harvard University, USA
- University of California--San Francisco, USA
- Stanford University, USA
- Yale University, USA
- Johns Hopkins University, USA
Industries associated with Vaccines in worldwide:
- GlaxoSmithKline plc (U.K.)
- Pfizer, Inc. (U.S.)
- Merck & Co., Inc. (U.S.)
- Sanofi Pasteur SA (France)
- CSL Limited (Australia)
- Emergent BioSolutions, Inc. (U.S.)
- Johnson & Johnson (U.S.)
- MedImmune, LLC (U.S.)
- Daiichi Sankyo Company, Limited (Japan).
- Mitsubishi Tanabe Pharma Corporation (Japan)
- Astellas Pharma Inc. (Japan)
- Serum Institute of India (India)
- Bavarian Nordic (Denmark)
Conclusion
Vaccines are necessary — and good hygiene, sanitation, clean water, and nutrition are insufficient for stopping infectious diseases. If we don’t maintain optimum rates of immunization or “herd immunity”, the diseases prevented by vaccination will return. While better hygiene, sanitation and clean water help protect people from infectious diseases, many infections can spread regardless of how clean we are. If people are not vaccinated, diseases that have become uncommon such as pertussis (whooping cough), polio and measles, will quickly reappear.
References
https://www.marketsandmarkets.com/PressReleases/vaccine-technologies.asp
http://www.who.int/immunization/programmes_systems/procurement/market/en/
https://www.technavio.com/report/global-vaccines-human-market
https://www.aboutpharma.com/blog/2017/05/02/global-influenza-vaccine-market-will-increase-to-us-5-74-billion-by-the-year-2022-research-and-markets/
- New Vaccines
- Infectious diseases & Non Infectious Diseases
- Cancer Vaccines
- Veterinary Vaccines
- Trials in Vaccinology
- Novel Vaccines
- Pregnancy & Neonantal Vaccines
- Vaccine-Preventable Diseases
- Therapeutic Vaccination and Immunizations
- Passive vaccines-therapeutic antibodies against infectious diseases
- Vaccine Regulation and its Safety & Efficacy
- Emerging and Re-emerging diseases
- Hepatitis Vaccines
- HIV/AIDS Vaccines
- Journal of Vaccines & Clinical Trials
11 Organizing Committee Members
Wu Ke
Chair and CEO
BravoVax
China
Nathalie Garcon
CEO
IRT BIOASTER
France
Giulio Tarro
Professor
Foundation T. & L. de Beaumont Bonelli
Italy
Ivana Haluskova balter
Member
French society of immunology
France
Daphne Sawlwin
Therapeutic Area Safety Head
Seqirus, A CSL Company
Australia
Benjamin Damien
Director of Business development
UNIVERCELLS
Belgium
Patrick Lecine
Scientific Expert in Immunology and Vaccines
BIOASTER
France
Guy Cardineau
Professor
Arizona State University
USA
Guy Cardineau
Professor
Arizona State University
USA
Peter L. Nara
Chief Executive Officer, President, Chairman & co-founder
Biological Mimetics, Inc
USA
Henri ATLAN
Director of Research
EHESS
France
Media Partners & Collaborations
Media Partner
Media Partner
fgsg
tgh
Dear Eliza, Thank you for that wonderful opportunity given to share my experiences during the conference. I would like to place on record the smooth conduct of the conference. My appreciation goes a long way to Eliza for her timely communication and well advanced information disseminated processes. The presentation schedule and the time mentioned in the mail sent were also strictly followed. All the best. Regards Kalyani Kenneth Speaker | Psychiatry-2021
Kalyani Kenneth
Dear Laura, Thank you for giving me the opportunity to present my current work! I really enjoyed listening and connecting to a wider international scientist through this conference. And I am really looking forward for the physical conference next year! Best regards Sharmaine
Sharmaine Reintar
Many thanks Laura. It iş my plesure work with you
Pinar Kara
It was my pleasure to be a part of the conference. The talks were technically profound. Thank you once again.
Anupam Mukherjee
Thank you very much for the message. I am glad that the presented poster was appreciated. I'm also grateful for the certificate. Dispite my main work was the subject presented in the session, it would be a pleasure to participate in the webinars.
Ana Rita Domingues
Thank you for your appreciation. I love the support received from you and your admirable patience from invitation till the end of the conference. Thank you very much. I hope to participate in future conferences.
Munezza Khan
Am really grateful for you inviting me to this great event... Am thrilled to be part of this great team, I feel honored 😀😃😄🤝🏻
Aysha Haruna
The conference was arranged nicely through a Webex. I found the sessions interactive and informative. I am looking forward to join the next annual meeting of plant genomics in osaka, japan in april 2022.
Ruchika
Highly appreciate your quick response and I am grateful for all your help.
Dr. P T Sunderam
Informative and Innovative sessions
Michael Lacroix
Delightful event with a wonderful sessions
Mohamed Ebraheem Elmesserey
Very much grateful for this opportunity to share the innovative ideas
Mahmoud Metwaly Taha
It was really informative and excellent platform to share the research ideas
Raktima Chakrabarti
Wonderful experience
KHALED NASR ELDIN REYAD
Thank you very much for organizing this wonderful conference
JIMMY KAYASTHA
it was impressive and left me a very good memory.
VAISHALI SAMIR JOSHI
I learnt a lot from the conference and hope to attend the next conference
Deepak Mane
It was a nice and well-organized meeting! Thank you for all your efforts of having put it together.
Vladimir Startsev
The conference was exciting. I enjoyed so much meeting new colleagues at the venue. I would like to express my sincere gratitude to you for your assistance and opportunity. It was a good experience attending this conference.
Daniela Capdepon
It was great being a part of Surgery 2021
Hadi Nural
How much I appreciate your support, you and your job are meaningful. I always wish the best for you. Thank Laura a lot
Kevin Ton
Hats off to you and fellow organizers. Great opportunities for sharing and networking!
Karen Swanepoel
It was a pleasure to participate in this year’s meeting (even in webinar format due to the COVID-19 pandemic) and I hope the participants enjoyed my talk. There were some interesting talks taking place today and the whole experience was enjoyable like last year. Please rest assured that I will be happy to join next year’s meeting as well, hopefully with a physical presence.
Vasileios Fotopoulos
It was my pleasure to attend this conference. Thanks for your kind efforts.
Saeed Taheri
Thank you for your effort for having made "Pharmacology 2019 conference" wonderful success. Thank you again for that.
Ryong Nam Kim
Thanks for holding a nice conference.
Ramin Ataee
I enjoyed the conference. Italy will be a great place to have the next conference. I look forward to 2020 edition.
Paul Njiruh Nthakanio
I am very happy to make a seminar in the conference. If I have a chance to present my work in your conference, I would talk it in your conference in future.
Takayuki Momma
It was good to connect with a diverse group of scientists - thanks very much for the invite
Thomas P Brutnell
It was a nice experience for me to attend plant genomics conference in Osaka and meet researchers from different countries.
Behnam Derakhshani
It has been an excellent experience.Thank you a lot for this opportunity. I enjoyed it very much!
Julio Cesar Vega
I definitely would like to join your conference again. It was so great about everything. I think I would say great coordination and services.
Maryam Jenabi
Great experience being a part of this conference as a moderator
Soizic de Beaucorps
Amazing experience full of knowledge and meeting new people. Looking forward to being back
Thomas Frederick Hartley
Thanks a lot. It was an excellent event. Really enjoyed.
Umesh Prabhu
It was a pleasure and a great opportunity to be one of the Keynote speakers. I welcome the opportunity to speak at additional conferences in the future. Please keep my contact information for future consideration.
Sharon Nixon-Crenshaw
Thank you for assisting in my participation in a superbly organized Conference. I especially appreciate that you made a special session for me. And once again, sincerely thank you for inviting me to the Conference.
Albert Krashenyuk
Thank you for all your help for the meetings. It was for me a great experience to be in a kind and so scientific group.
Katia lollai
I enjoyed a lot thank you. I thank Meetings International for the quality of the event. All the speakers i had notice of were well prepared and highly motivated Compliments!
Dora Dragoni Dıvrak
Thank you for organizing the conference. It was nice to partake in the event.
Marcello Menapace
I enjoyed participating in the congress and thank you for your efforts to make it easy for participants. Please keep me in mind for future meetings.
Debendra Kumar Tripathy
It was a nice meet and we had a wonderful time in Paris Thank you once again for the arrangement. I would be interested in participating future meetings.
Prasanna Udupi Bidkar
Thank you so much for giving me a chance to my research presentation in your conference.
Seyedataollah montazam
I enjoyed being in the conference. Thanks for you excellent arrangement for my participation. Looking forward for next meetings.
Afaf El Ansary
The conference is very nice, Thank you so much for inviting me to your esteemed event.
Esmira Naftali
The conference was very good. I hope to attend similar meeting in future. Thank you .
Lia Monica Junie
I am indeed glad to acknowledge that for last two days during Optics-2018, International conference on Lasers, Optics and Photonics it was Successfully conducted and we had very fruitful discussions and interactions to make many great friends for life. Many Delegates had interactions with many famous Japanese University Professors and company Managers too for their future possibilities of R&D collaborations. I had arranges a session for such interactions while eating and discussing with relaxed environment and taking group pictures. The hospitality provided by your Organization Committee Members was excellent to help completing Conference Inauguration, all Keynote Speeches, Oral Presentations And Poster session had very high-quality research presentations in many advanced research areas such as Spectroscopy, Ultra high power Lasers, Fibers, Advances in stabilized high frequency mode-locked pulsed Fiber Lasers, MEMS, Optical Interconnects, Photonics and Advanced Optical Biomedical Imaging, THz and optical communications and Interconnects, theoretical and experimental research and so on from highly recognized Professors and Researchers in Japan and advanced institutions in many advanced countries.
Dr. Brahm Pal Singh
I wish to thanks you for my perfect time on conferense in Osaka. It was great experience for me.
Anton Podkopaev
I wish to thanks you for my perfect time on conferense in Osaka. It was great experience for me.
Dr. Anton Podkopaev
I would refer this organization future conferences to my colleagues and also love to join again in diabetes related events. More topics on diabetes should be there in future diabetes conferences.
Radia Boufermes
Thank you for the invitation and the opportunity to participate. It was very good.
Juliana Francisca Grossi Heleno
Thank you very much for the invitation and it was a great honor for me to join this conference. I had a great time.
Alkis Konstantinopoulos
It was a good event and got to make good friends out there.
Nur Ozel
Thank you so much. Really we appreciate the Congress, hope next time it will be longer. Everything was ok, the venue, colleagues, organizing team. Thank you and hope to meet soon in other Congress soon.
Sameh Samy Abdou
It was a great pleasure of mine to be there during the conference looking forward to joining your future conferences
Ahmed Halim Ayoub
The theme of the conference and the scientific panel are very interesting! I am looking excited to learn many new things on this innovative platform
Lisa mattheu
I would love to attend the Infectious Diseases 2019 conference. The hospitality, the renowned speakers, and the city are awesome. Looking forward to it!
Dr. Ianane Jireh Ramos canizares
Hello Daniel, Thank you for the invitation to the conference. It was an interesting experience. I am glad that my presentation was liked. Like the effects of my work. Stay in touch. Best Regards !
Aneta Zymon
Thank you to Daniel Raybin with Wound Care 2018 for allowing me to be the Keynote Speaker for the conference. Dr. Jeff Mayo and I met colleagues from other countries such as Poland and Ukraine that work in plastic medicine and surgery. We are excited to share our knowledge of wound care in the veterinary industry so that our human medicine counterparts can offer the same standardized care that we utilize in the US. Thank you to Regenlabs for sponsoring the event and Jorgensen Laboratories for providing us with a great sponsor to represent our mission.
Nicole LaForest
Dear Daniel! Thank you for the conference, for your accommodation and the opportunity to see the most romantic, mysterious, fabulous Amsterdam
Nadiia Nor
Congress was good, the quality of the presentations was good. The choice of Singapore as strategic headquarters has been good
Buonocore D
Thanks for your invitation. I enjoyed participating at he conference in Rome and am interested in participating again next year in Paris.
Daniel Benetti
Great experience!! Thanks a lot for the opportunity to speak.
Jose Carlos Ferreyra Lopez
Dear Julie, Many thanks to you as you offered me this opportunity to come and participate at this valuable event in Chicago. I think you are great professional and made huge efforts for the event in terms of organization, engaging speakers, etc. And also you have sense for people, act as empathic person what is very important for me. I was very happy and honored to be invited as a speaker at World Biosimilars Conference in terms to present company Ewopharma AG as business partner of different pharma companies in Central and Eastern Europe, especially company Biogen with its portfolio of biosimilars and share my commercial experience in launching biosimilars! I found the conference interested in terms you selected very qualitative speakers from different areas: innovation and science, manufacturing and commercialization. From my perspective, the most interesting topics were: Sarfaraz K Niazi: “Biosimilars: Why are they so widely misunderstood?” Ronald P Dudek: “The adapter CAR Platform: From antibody to CAR T cell therapeutic” Jose Carlos Ferreyra Lopez: “Market access barriers and market value in Mexican public sector for biosimilars” Milind Antani: “Similar biologics in India- Impact of regulations on business” Joel I Osorio: “RegenerAge System “ (So I will be very happy if you could share these mentioned presentations with me!). I can see more potential for further improvement to put 100% focus on Biosimilar topics and to attract more specialists/professionals to gather. It will be excellent if you could attract more speakers from Europe to share their experience. So please consider this option how to attract them in the future (if I got some nice ideas will share with you!).
Sandra Simic
Thanks for giving opportunity to share my research at 3d printing conference .I meet global experts and exchange our ideas.Two days conference are going very good ,workshop session,exhibition .I felt moved to contribute next year also..
Rajkumar Velu
It is wonderful conference of 3d printing & Bio printing in health care .participates are coming from world wide 3d printing & Bio printing experts .Workshop sessions is too good .
Lifeng Kang
• Good workshop session at conference with lots of discussion among audiences and speakers about the regulatory aspect of 3D printed medical devices. • Many of the topics were good and interesting. • It will be good if the organizer could have invited more participants as well as selecting the speakers based on proven and relevant track record. • It will be better if there are people who keep track of the time for each topic.
Albert Sutiono
Conference was superb. It was well conducted. I appreciate all the speakers, presenters and organizers. I am very proud to be part of this event.
Rajani singh
We had a very good session at cardiomersion in which we discuss about the integrated cardiomersion approach to the delivery of cardiovascular case. Thank you to all the speakers who came across the globe. Finally I would like to thank the organizers for making such a remarkable event.
Deepak Puri
I have been a part of this conference and I am very proud to see the conference very well organized and people are helping us and each other to present their case reports and research. Thank you very much to the organizers for making such great events
Suresh Vatsyayan
The event was very nice and I want to thank all the participants, presenters and the organizers. We hope in future we will have more events like this
Yuan Chen
The BABE conference was very interesting and lot of scientific sessions were covered and highlighted. Special thanks to the Organizing Members and the participants
Kateryna Zupanets
Conference was good, thanks for organising. I felt moved to contribute throughout, and felt that to a certain extent I acted as a moderator throughout the event .It is very happy for me.
Alexander M. Korsunsky
I want to express my graduate and thanks to you for all efforts you put to organize such a successful conference. For 2 days I enjoyed the company of brilliant and beautiful minds from all over the world. I had a great chance to exchange expercties with them and in large my horizons. I want to thank you again for organizing the International Conference of Petroleum Engineering 2018, Dubai, UAE and hope to meet you again very soon.
Essa Georges Lwisa
I enjoyed participating in the congress and thank you for your efforts to make it easy for participants. Please keep me in mind for future meetings relating to bariatric surgery, I would be interested in participating or being part of the organizing committee.
Peter Harris
Meetings International meetings are great way to receive way to receive other scientists in different parts of the world doing, These meetings provides the opportunity for you to work at latest concepts from different peoples also specifically it allows the opportunity to call to the new relationships when it resolves in future collaboration across the photolamps
Suzanne Tinsley
I enjoyed conference with Meetings International it is a mutal legitimate.It is always with first move which encourages scientists for practicing ability based practice It also gives lots of opportunity for discussions as well as collaborations in future
Dr. Marie Vazquez Morgan
We enjoyed the meeting so much. Wish you all success in the coming meetings.
Richa Jaiswal
It was a great experience for us to attend the conference. Had good interactions with speakers. Many thanks to you and Mr Peter Harris for giving us opportunity to participate and visit Japan as well. Wish to attend further conferences in future!
Kalpana Kulkarni
The first day was very good. It was meaningful to spend academic meeting. I thank you for your consideration.
Gagan Dhall
International meeting was good looking forward for next meetings.There can be more we can do because there is always scope for improve.
Suman Lata
Thanks for your greeting letter! We enjoyed the conference. Sure! We will meet again in 2019!
Dra Milagrosa C. S. Liu
First of all I would like to say many thanks to YOU and The Organization / Planning Committee, for I have been given the opportunity to join in this very Prestigious Event. I am also grateful to meet with researchers from other countries who have innovative research’s. Hopefully it could upgrade to my knowledge and more increases my interest in this field of science. Nice to join in this event I wish i could be join on the Traditional Medicine 2019.
Yunita Sari Pane
It was great experience for me. My talk was very much liked by all receipients at Osaka.
Mohammad Kamil
I am indeed glad to acknowledge that for last two days during Optics-2018, International conference on Lasers, Optics and Photonics it was Successfully conducted and we had very fruitful discussions and interactions to make many great friends for life. Many Delegates had interactions with many famous Japanese University Professors and company Managers too for their future possibilities of R&D collaborations. I had arranges a session for such interactions while eating and discussing with relaxed environment and taking group pictures. The hospitality provided by your Organization Committee Members was excellent to help completing Conference Inauguration, all Keynote Speeches, Oral Presentations And Poster session had very high-quality research presentations in many advanced research areas such as Spectroscopy, Ultra high power Lasers, Fibers, Advances in stabilized high frequency mode-locked pulsed Fiber Lasers, MEMS, Optical Interconnects, Photonics and Advanced Optical Biomedical Imaging, THz and optical communications and Interconnects, theoretical and experimental research and so on from highly recognized Professors and Researchers in Japan and advanced institutions in many advanced countries.
Dr. Brahm Pal Singh
I wish to thanks you for my perfect time on conferense in Osaka. It was great experience for me.
Dr. Anton Podkopaev
Interesting presentation & worthfull spirit of exchange of experience
Ippei Sakamaki
Thanks a lot we hade a great time and grest conference. We enjoyed the conference .
Chi-Ying Huang
I would like to express my gratitude for your engagement in preparation of the Cancer Therapy Summit 2018. It was a valuable experience.
Hong Qin
Conference was good. Thanks for your support and co operation.
GURUSAMY MARIAPPA
My active partecipation to the Toronto meeting is just over and motivated by it and by Joseph Ndisang who I met there, I'd like to ask and verify whether I could further collaborate more actively, with no expenses for it, within yr network with my long term scientific expertise and long background in the field of diabetes and also at the light of my previous experience with you over the last year.
Marco Songini
“ The organisation and coordination of the international conference of nanotechnology and nanoengineering was at an outstanding level, it was a great honour to participate in such phenomenal event “
Ahmed Abushomi
I also really appreciated all the scientific contact I made within all these participants - Think that in the future if you might request some help for that renewal activity, I might be helping your team of course (I have some suggestions for making better sort / type of presentation activities for invited speakers of course according to my experience in the field).
Jean-paul Lellouche
The conference sesions proceeded successfuly in a hot and friendly atmospher. I observed during the conference every delegate and speaker interacted wit each other and made friend. I am sure that the conference has become a scientific platform to exchange knowledge among the scientists from all over the world, and they wil conduct a new collaborations. During the conference, onsite organizers spent a great efford. I believe that the level and quality and reputation will increase year to year. Unexpected and unavoidable circumstances can occur at everywhere and every activation, and they can be solved easily. Hope to meet you and your team in another conference.
Osman Adiguzel
Thank you for your friendly mail. I enjoyed the conference with interesting speakers. I did not know anybody at the beginning but I found good companions during the conference.The hotel was good but it was located somewhat outside of Paris. Nevertheless, we had a good time. Anyway, thank you again for your invitation.
Nikolaus Stolterfoht
Thank you. Yes the conference was really interesting.
Adil Aghzar
Thank you! I also think that the event was very successful and very interesting. The variety of thematic session and possibility to meet experts from different fields of marine biology and aquaculture was the biggest advantage of the conference. However, it might be useful to attract more participants to next conference.
Magdalena Jakubowska
Thank you for your kind welcome and appreciated support during the appreciable meeting. Thank you for your kind offer to continue to cooperate to this interesting initiative and I am available to cooperate again in remote and to eventually attend the conference. Thank you and your colleagues and the scientific valuable people that attended the conference for your kind cooperation.
Gianluca Ragusa
Thank you for allowing me to participate in this event, I liked the organization and the people who participated, I made many friends too. Of course I would like to collaborate with you in organizing the next Aqua 2019 conference.
Alfredo Olivera Galvez
The meeting was a success with many experience professional.
Nyan Taw
A very thorough and well written set of points. It’s great that you took the time to put this together.
Feng Gao
Thank you for offering an unforgettable experience for all of us. We are honored to attend the conference. We are so happy and thanks a lot.
Stef Stienstra
Many thanks for your continuous support throughout the conference. It was the pleasure to participate and shared the findings at such high level meetings.
Pooja Jain
The conference was very enjoyable and I was honoured to be able to present my research at this prestigious event. The conference was particularly good for me as it is always important to keep up with the new developments
Glenda Gray
I had a wonderful time at the conference and learned so much from the presenters. Thank you kindly for putting this event together.
Marc HV Van Regenmortel
I had a great time in the conference, Everythings are OK, thank you .
Hsiao-Hui Chiu
Wonderful!! thank you for all the help you have done
Sharadha Ramesh
Thank you for your arrangement. Our team enjoyed the meeting so much. Wish you all success in the coming meetings!
CHAN Yui Fung
Surely we will maintain our relation in long run. If there is any opportunity for me to start my carrier being fresher and any guidance from you to me. It will be highly appreciated.
Monika kankarwal
I appreciate your polite contact. I enjoyed my first visit to Singapore. It was meaningful to spend academic meeting. I thank you for your consideration.
Kazue Sawami
Thank you for the email ,it was my sincere honor and pleasure to participate , many thanks for the invitation ,well organised conference, great hospitality ,well composed programme,interesting nursing topics, but not very large group size enough group size to be conducive to excellent discussions, I wish you all the success for your further conference
Hana Kadhom
Thank you for successful conference in Singapore. And thank you for giving me opportunity of oral presentation. It was very good experiences to me.
Hyun, Myung sun.